Longitudinal Validation of the ALS-FTD-Questionnaire - Preliminary Results (P3.180)

Conclusions: These preliminary results (we expect to present twice as many patients at the AAN congress) provide some evidence for longitudinal construct validity of the ALS-FTD-Q and show no progression of behavioral disturbances at 3-6 months follow-up. We recently added a behavioral interview with a proxy (gold standard) in order to investigate the longitudinal clinimetric properties of the ALS-FTD-Q.Disclosure: Dr. Govaarts has nothing to disclose. Dr. Beeldman has nothing to disclose. Dr. Beelen has nothing to disclose. Dr. Grupstra has nothing to disclose. Dr. Van Der Kooi has nothing to disclose. Dr. De Haan has nothing to disclose. Dr. Schmand has nothing to disclose. Dr. Raaphorst has nothing to disclose. Dr. de Visser has received research support from Biogen Idec.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Govaarts, R., Beeldman, E., Beelen, A., Grupstra, H., Van Der Kooi, A., De Haan, R., Schmand, B., Raaphorst, J., De Visser, M. Tags: Motor Neuron Disease: Clinical Trials, Treatment, and Outcome Source Type: research